Concordance of HER2 Testing in Breast Cancer


Concordance of HER2 Testing in Breast Cancer
Slides from presentations at SABCS 2010 and transcribed comments from a recent interview with William J Gradishar, MD (1/4/11)

Perez EA et al. Round-robin review of HER2 testing in the context of adjuvant therapy for breast cancer (NCCTG N9831/BCIRG006/BCIRG005). San Antonio Breast Cancer Symposium 2010;Abstract PD10-02.

McCullough AE et al. Concordance of HER2 central assessment by two international central laboratories: A ring study within the framework of the adjuvant HER2-positive ALTTO trial (BIG2-06/N063D/EGF106708). San Antonio Breast Cancer Symposium 2010;Abstract P3-10-36.

Dr Gradishar is Director of Breast Medical Oncology at the Robert H Lurie Comprehensive Cancer Center and Professor of Medicine at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.